127 related articles for article (PubMed ID: 37289477)
1. Starving multiple myeloma cells via CDK7 inhibition.
Sacco A; Roccaro AM
Blood; 2023 Jun; 141(23):2787-2788. PubMed ID: 37289477
[No Abstract] [Full Text] [Related]
2. CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.
Yao Y; Ng JF; Park WD; Samur M; Morelli E; Encinas Mayoral J; Chyra Z; Xu Y; Derebail S; Epstein C; Nabet B; Chesi M; Gray NS; Young RA; Kwiatkowski N; Mitsiades C; Anderson KC; Lin CY; Munshi NC; Fulciniti M
Blood; 2023 Jun; 141(23):2841-2852. PubMed ID: 36877894
[TBL] [Abstract][Full Text] [Related]
3. The Covalent CDK7 Inhibitor THZ1 Potently Induces Apoptosis in Multiple Myeloma Cells
Zhang Y; Zhou L; Bandyopadhyay D; Sharma K; Allen AJ; Kmieciak M; Grant S
Clin Cancer Res; 2019 Oct; 25(20):6195-6205. PubMed ID: 31358538
[TBL] [Abstract][Full Text] [Related]
4. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.
Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP
PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759
[TBL] [Abstract][Full Text] [Related]
5. Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma.
Tong WG; Chen R; Plunkett W; Siegel D; Sinha R; Harvey RD; Badros AZ; Popplewell L; Coutre S; Fox JA; Mahadocon K; Chen T; Kegley P; Hoch U; Wierda WG
J Clin Oncol; 2010 Jun; 28(18):3015-22. PubMed ID: 20479412
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase activating kinase/Cdk7 co-localizes with PKC-iota in human glioma cells.
Bicaku E; Patel R; Acevedo-Duncan M
Tissue Cell; 2005 Feb; 37(1):53-8. PubMed ID: 15695176
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the cyclin-dependent kinases at the beginning of human cytomegalovirus infection specifically alters the levels and localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and cdk7 at the viral transcriptosome.
Kapasi AJ; Spector DH
J Virol; 2008 Jan; 82(1):394-407. PubMed ID: 17942543
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase 7 inhibitors in cancer therapy.
Wang M; Wang T; Zhang X; Wu X; Jiang S
Future Med Chem; 2020 May; 12(9):813-833. PubMed ID: 32208930
[TBL] [Abstract][Full Text] [Related]
10. Meiotic expression of the cyclin H/Cdk7 complex in male germ cells of the mouse.
Kim JM; McGaughy JT; Bogle RK; Ravnik SE
Biol Reprod; 2001 May; 64(5):1400-8. PubMed ID: 11319144
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of CDK7-associated human MAT1, a cyclin-dependent kinase-activating kinase (CAK) assembly factor.
Yee A; Nichols MA; Wu L; Hall FL; Kobayashi R; Xiong Y
Cancer Res; 1995 Dec; 55(24):6058-62. PubMed ID: 8521393
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of cyclin H and CDK7 in human hemangiomas].
Liu J; Zhang DL; Shan SG
Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Jul; 24(4):300-2. PubMed ID: 18950027
[TBL] [Abstract][Full Text] [Related]
13. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.
Larochelle S; Merrick KA; Terret ME; Wohlbold L; Barboza NM; Zhang C; Shokat KM; Jallepalli PV; Fisher RP
Mol Cell; 2007 Mar; 25(6):839-50. PubMed ID: 17386261
[TBL] [Abstract][Full Text] [Related]
14. Is Cdk7/cyclin H/MAT1 the genuine cdk activating kinase in cycling Xenopus egg extracts?
Fesquet D; Morin N; Doree M; Devault A
Oncogene; 1997 Sep; 15(11):1303-7. PubMed ID: 9315098
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy.
Liang H; Du J; Elhassan RM; Hou X; Fang H
Expert Opin Investig Drugs; 2021 Jan; 30(1):61-76. PubMed ID: 33183110
[No Abstract] [Full Text] [Related]
16. An integrative multi-omics approach uncovers the regulatory role of CDK7 and CDK4 in autophagy activation induced by silica nanoparticles.
Ruan C; Wang C; Gong X; Zhang Y; Deng W; Zhou J; Huang D; Wang Z; Zhang Q; Guo A; Lu J; Gao J; Peng D; Xue Y
Autophagy; 2021 Jun; 17(6):1426-1447. PubMed ID: 32397800
[TBL] [Abstract][Full Text] [Related]
17. Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells.
Lawrie AM; Tito P; Hernandez H; Brown NR; Robinson CV; Endicott JA; Noble ME; Johnson LN
Protein Expr Purif; 2001 Nov; 23(2):252-60. PubMed ID: 11676600
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
Bockstaele L; Bisteau X; Paternot S; Roger PP
Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
[TBL] [Abstract][Full Text] [Related]
19. The CDK-activating kinase Cdk7: taking yes for an answer.
Schachter MM; Fisher RP
Cell Cycle; 2013 Oct; 12(20):3239-40. PubMed ID: 24036541
[No Abstract] [Full Text] [Related]
20. A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022).
Kovalová M; Baraka JP; Mik V; Jorda R; Luo L; Shao H; Kryštof V
Expert Opin Ther Pat; 2023 Feb; 33(2):67-87. PubMed ID: 36975020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
